The Gross Margin of Soleno Therapeutics Inc (SLNO) is 40.98%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 40.98% |
| 2023-12-31 | 42.62% |